JCI
GSK icon

Jet Capital Investors’s GSK GSK Stock Holding History

Jet Capital Investors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-508,000
Closed -$28M – 30
2022
Q1 		$27.7M Buy
508,000
+188,000
+59% +$10.2M 4.34% 7
2021
Q4 		$17.6M Buy
320,000
+200,000
+167% +$10.4M 4.67% 7
2021
Q3 		$5.73M Buy
+120,000
New +$6.03M 0.98% 18

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Jet Capital Investors's GSK Position: Q2 2022 in Review

Jet Capital Investors sold out of GSK (GSK) in Q2 2022, closing a stake of 508,000 shares — an estimated $28M sold.

Jet Capital Investors first reported a position in GSK in Q3 2021 and held it in 3 quarters. The position peaked at $27.7M in Q1 2022. 900 funds tracked by Wall St. Rank hold GSK as of Q2 2022.

  • Jet Capital Investors reported no remaining GSK position as of Q2 2022 after selling out during the quarter.
  • Jet Capital Investors sold 508,000 GSK shares in Q2 2022, an estimated $28M.
  • Jet Capital Investors first reported a position in GSK in Q3 2021 and held it in 3 quarters.
  • Jet Capital Investors's GSK position peaked at $27.7M in Q1 2022.
  • 900 funds tracked by Wall St. Rank held GSK as of Q2 2022.

Based on Jet Capital Investors's 13F filing for Q2 2022, filed 15 Aug 2022.